Preventive Treatment Health Care Act addresses chronic weight disease in California.

The Preventive Treatment Health Care Act aims to tackle chronic weight disease in California by authorizing the California Health and Human Services Agency to form partnerships to increase competition, lower prices, and address supply shortages for GLP-1 antiobesity medications. The act also allows partnerships for over-the-counter naloxone products, generic or brand name drugs, and vaccines. The legislation seeks to mitigate the economic and health impacts of chronic weight disease, which affects nearly 61% of California adults and is linked to over 200 comorbid conditions.

Preventive Treatment Health Care Act addresses chronic weight disease in California.

The Preventive Treatment Health Care Act aims to tackle chronic weight disease in California by authorizing the California Health and Human Services Agency to form partnerships to increase competition, lower prices, and address supply shortages for GLP-1 antiobesity medications. The act also allows partnerships for over-the-counter naloxone products, generic or brand name drugs, and vaccines. The legislation seeks to mitigate the economic and health impacts of chronic weight disease, which affects nearly 61% of California adults and is linked to over 200 comorbid conditions.